MedReleaf said Thursday in a statement that it’s had talks with companies including Aurora “regarding various alternatives.” Aurora said the same in a separate statement. The Globe and Mail reported Wednesday that MedReleaf has contacted larger companies about a sale and that Aurora was engaged in talks.
MedReleaf rose 2.2 percent in Toronto to close at C$22.25, giving it a market capitalization of $2.2 billion. Aurora climbed 0.9 percent to C$8.02 for a valuation of $4.5 billion.
Continue Reading at Bloomberg.com